{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:12:36Z","timestamp":1793707956277,"version":"4.6.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":1409,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Heart failure (HF) substantially limits the ability of patients to engage in physical activities. A detailed understanding of how patients experience these limitations is required to develop valid and sensitive measures for use in clinical research. This qualitative study was designed to provide a thorough description of how HF patients experience physical activity limitations in their daily lives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Semi-structured interviews were conducted with 40 HF patients. Interview transcripts were coded with the aim of identifying key aspects of physical activity. Patients were divided between HF with preserved ejection fraction (n = 21, 52.5%) and HF with reduced ejection fraction (n = 19, 47.5%); the majority of patients were New York Heart Association Class II (n = 22, 52.5%) or Class III (n = 16, 40.0%). Relevant physical activity themes, including mobility and broader daily function areas, were identified. The most frequently reported mobility limitations involved difficulty walking (up a steep incline, up steps, and long distances), limited walking speed, difficulty standing for long periods of time, and difficulty carrying and lifting objects. These limitations were principally related to three HF symptoms: dyspnoea, tiredness\/fatigue, and peripheral oedema. Patients adapted to their symptoms and related mobility limitations in several ways, including taking rests during an activity, doing an activity more slowly, and avoiding\/refraining from an activity altogether. The broader daily function areas most commonly impacted by the mobility limitations were housework, exercising or playing sports, and going shopping.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Heart failure patients report numerous physical activity limitations. These specific mobility and daily function areas can be measured using clinical outcome assessments (e.g. patient-reported outcomes and performance outcomes) in clinical trials and observational research. Accelerometry can be used to contribute to a holistic picture of patient functioning by passively collecting this type of data.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13795","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T19:49:36Z","timestamp":1643226576000},"page":"1206-1215","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Living with Heart Failure: Patient Experiences and Implications for Physical Activity and Daily Living"],"prefix":"10.1093","volume":"9","author":[{"given":"Anna","family":"Niklasson","sequence":"first","affiliation":[{"name":"AstraZeneca , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1889-8931","authenticated-orcid":false,"given":"Joshua","family":"Maher","sequence":"additional","affiliation":[{"name":"IQVIA , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakshit","family":"Patil","sequence":"additional","affiliation":[{"name":"IQVIA , Bangalore ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Sill\u00e9n","sequence":"additional","affiliation":[{"name":"AstraZeneca , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jersey","family":"Chen","sequence":"additional","affiliation":[{"name":"AstraZeneca , Gaithersburg, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Gwaltney","sequence":"additional","affiliation":[{"name":"Gwaltney Consulting , Westerly, RI ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ryd\u00e9n","sequence":"additional","affiliation":[{"name":"AstraZeneca , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"2026012114165634500_ehf213795-bib-0001","volume-title":"Treatment for Heart Failure: Endpoints for Drug Development Guidance for Industry","author":"FDA","year":"2019"},{"key":"2026012114165634500_ehf213795-bib-0002","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003358","article-title":"Exploring new endpoints for patients with heart failure with preserved ejection fraction","volume":"9","author":"Butler","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026012114165634500_ehf213795-bib-0003","volume-title":"Guideline on clinical investigation of medicinal products for the treatment of chronic heart failure","author":"EMA"},{"key":"2026012114165634500_ehf213795-bib-0004","volume-title":"Medical device development tool (MDDT) qualification decision summary for Kansas City Cardiomyopathy Questionnaire (KCCQ)","author":"FDA"},{"key":"2026012114165634500_ehf213795-bib-0005","volume-title":"Medical device development tool (MDDT) qualification decision summary for Minnesota Living with Heart Failure Questionnaire (MLHFQ)","author":"FDA"},{"key":"2026012114165634500_ehf213795-bib-0006","volume-title":"Qualification of the Kansas City Cardiomyopathy Questionnaire clinical summary score and its component scores: a patient-reported outcome instrument for use in clinical investigations in heart failure","author":"FDA","year":"2020"},{"key":"2026012114165634500_ehf213795-bib-0007","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/CIRCULATIONAHA.119.044138","article-title":"Effects of dapagliflozin on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction: results from the DAPA-HF trial","volume":"141","author":"Kosiborod","year":"2020","journal-title":"Circulation"},{"key":"2026012114165634500_ehf213795-bib-0008","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1007\/s11136-020-02537-y","article-title":"Development of a conceptual model and patient-reported outcome measures for assessing symptoms and functioning in patients with heart failure","volume":"29","author":"Moshkovich","year":"2020","journal-title":"Qual Life Res"},{"key":"2026012114165634500_ehf213795-bib-0009","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000507696","article-title":"Real-life multimarker monitoring in patients with heart failure: continuous remote monitoring of mobility and patient-reported outcomes as digital end points in future heart-failure trials","volume":"4","author":"Kramer","year":"2020","journal-title":"Digit Biomark"},{"key":"2026012114165634500_ehf213795-bib-0010","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/ehf2.12781","article-title":"Advances in accelerometry for cardiovascular patients: a systematic review with practical recommendations","volume":"7","author":"Vetrovsky","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026012114165634500_ehf213795-bib-0011","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.003878","article-title":"Accelerometer-measured daily activity in heart failure with preserved ejection fraction: clinical correlates and association with standard heart failure severity indices","volume":"10","author":"Snipelisky","year":"2017","journal-title":"Circ Heart Fail"},{"key":"2026012114165634500_ehf213795-bib-0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2021.106433","article-title":"Patient-centered mobile health technology intervention to improve self-care in patients with chronic heart failure: protocol for a feasibility randomized controlled trial","volume":"106","author":"Kitsiou","year":"2021","journal-title":"Contemp Clin Trials"},{"key":"2026012114165634500_ehf213795-bib-0013","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.5837\/bjc.2012.004","article-title":"Hearing the voice of the heart failure patient: key experiences identified in qualitative interviews","volume":"19","author":"Gwaltney","year":"2012","journal-title":"Br J Cardiol"},{"key":"2026012114165634500_ehf213795-bib-0014","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026012114165634500_ehf213795-bib-0015","volume-title":"Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims","author":"FDA","year":"2009"},{"key":"2026012114165634500_ehf213795-bib-0016","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","article-title":"Content validity\u2014establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2\u2014assessing respondent understanding","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health"},{"key":"2026012114165634500_ehf213795-bib-0017","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","article-title":"Content validity\u2014establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 1\u2014eliciting concepts for a new PRO instrument","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health"},{"key":"2026012114165634500_ehf213795-bib-0018","volume-title":"Content Analysis: An Introduction to Its Methodology","author":"Krippendorff","year":"2004"},{"key":"2026012114165634500_ehf213795-bib-0019","volume-title":"NodeXL: a free and open network overview, discovery and exploration add-in for Excel 2007\/2010\/2013\/2016","author":"Smith","year":"2010"},{"key":"2026012114165634500_ehf213795-bib-0020","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jchf.2016.04.010","article-title":"Patient-reported outcomes in chronic heart failure: applicability for regulatory approval","volume":"4","author":"Psotka","year":"2016","journal-title":"JACC Heart Fail"},{"key":"2026012114165634500_ehf213795-bib-0021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000486347","article-title":"Use of mobile devices to measure outcomes in clinical research, 2010\u20132016: a systematic literature review","volume":"2","author":"Perry","year":"2018","journal-title":"Digit Biomark"},{"key":"2026012114165634500_ehf213795-bib-0022","volume-title":"DDT COA #000114: Chronic Heart Failure-Activity Monitor-Based Endpoint Measure","author":"FDA","year":"2019"},{"key":"2026012114165634500_ehf213795-bib-0023","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000512513","article-title":"A roadmap to inform development, validation and approval of digital mobility outcomes: the Mobilise-D approach","volume":"4","author":"Rochester","year":"2020","journal-title":"Digit Biomark"},{"key":"2026012114165634500_ehf213795-bib-0024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ehjqcco\/qcy038","article-title":"Can activity monitors predict outcomes in patients with heart failure? A systematic review","volume":"5","author":"Tan","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026012114165634500_ehf213795-bib-0025","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0735-1097(19)31456-1","article-title":"Sleep outcomes from AWAKE-HF, a randomized clinical trial with open-label extension of sacubitril\/valsartan versus enalapril in patients with heart failure with reduced ejection fraction","volume":"73","author":"Owens","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026012114165634500_ehf213795-bib-0026","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/ejhf.1919","article-title":"Rationale and study design of OUTSTEP-HF: a randomised controlled study to assess the effect of sacubitril\/valsartan and enalapril on physical activity measured by accelerometry in patients with heart failure with reduced ejection fraction","volume":"22","author":"Edelmann","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026012114165634500_ehf213795-bib-0027","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s13063-019-3474-5","article-title":"Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)","volume":"20","author":"Jensen","year":"2019","journal-title":"Trials"},{"key":"2026012114165634500_ehf213795-bib-0028","volume-title":"Does gender influence online survey participation? A record-linkage analysis of university faculty online survey response behavior","author":"Smith","year":"2008"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13795","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13795","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/2\/1206\/65375453\/eschf_9_2_1206.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/9\/2\/1206\/65375453\/eschf_9_2_1206.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:20:22Z","timestamp":1769023222000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/9\/2\/1206\/8326213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1,26]]},"published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13795","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4]]},"published":{"date-parts":[[2022,1,26]]},"assertion":[{"value":"2021-05-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}